A esterigmatocistina (ST) é uma micotoxina policetônica produzida por diferentes espécies de Aspergillus e outros gêneros fúngicos como Bipolaris e Chaetomium. Esta toxina é caracterizada como uma bifuranoxantona com fórmula molecular C18H12O6, freqüentemente encontrada como contaminante de diversos produtos alimentícios como sementes oleaginosas e cereais. Possui propriedades carcinogênicas, toxigênicas, mutagênicas e teratogênicas, entretanto, ela é menos tóxica do que a aflatoxina. O fungo Emericella nidulans (Eidam) Vuillemin, cujo anamorfo é o Aspergillus nidulans (Eidam) Winter, foi usado como modelo genético para a investigação de genes envolvidos na via biossintética da esterigmatocistina. Linhagens estoque de Utrecht (originárias de Glasgow) foram analisadas quanto à produção de ST e, entre elas, somente a linhagem UT196 [yA2 (I); metA17 (II); piroA4 (IV)] apresentou produção de 4 ppm de ST (stc+), enquanto que as linhagens UT448 e UT184 mostraram-se não produtoras dessa micotoxina (stc). Embora a linhagem UT196 seja muito bem caracterizada geneticamente, este foi o primeiro relato da produção de ST nessa linhagem. Os índices de segregação alélica e todas as freqüências de recombinação entre os marcadores genéticos ligados e não ligados foram determinados tanto pelo cruzamento meiótico UT448 (stc) x UT196 (stc+) como pelo cruzamento mitótico UT448//UT184. 175 segregantes meióticos e 140 segregantes mitóticos foram analisados quanto à produção de ST, aos marcadores de auxotrofia e de resistência a acriflavina. Essas linhagens cruzadas apresentavam vários marcadores em heterozigose e isso permitiu o mapeamento de um gene estrutural da ST (stcZ+), localizado no braço esquerdo do cromossomo I, 4% distante do gene da riboflavina (riboA1). Como um subproduto deste trabalho, foi detectado um pigmento vermelho, de Rf = 0,90, em todos os segregantes meióticos e mitóticos, produtores ou não de ST, indicando tratar-se, provavelmente, de um pigmento policetônico produzido pelos ascosporos do fungo. A baixa expressão da produção de ST em 13 segregantes meióticos e a alta expressão dessa toxina nos diplóides UT448//UT196 e UT448//UT184 (40 ppm) permitiram concluir a existência de um fator regulador, compreendido na região w-met do cromossomo II, responsável pela expressão do gene estrutural stcZ+. A análise desses genes através do ciclo parassexual sugeriu um comportamento epigenético típico envolvendo esses genes. Com base nos dados obtidos, hipóteses para explicar o controle da expressão desses genes e suas inter-relações foram aqui apresentadas. / Sterigmatocystin (ST) is a polyketide produced by different species of Aspergillus as well as by other fungus genera such as Bipolaris and Chaetomium. This toxin is characterized as a bifuranoxanthone, whose molecular formula is C18H12O6 and which is frequently found as a contaminant in several food products such as oil-seed grains and cereals. It has carcinogenic, toxigenic, mutagenic and teratogenic properties; however, it is less toxic than aflatoxin. The fungus Emericella nidulans (Eidam) Vuillemin, whose anamorph is Aspergillus nidulans (Eidam) Winter, was used as a genetic model to investigate the genes involved in the sterigmatocystin biosynthetic pathway. Strains from Utrecht stocks (originally from Glasgow) were analyzed in order to detect ST production and, among them, only the UT196 strain [yA2 (I); metA17 (II); piroA4 (IV)] showed the production of 4 ppm of ST (stc+), whereas the UT448 and UT184 strains showed to be nonproducers of such toxin (stc). Although the UT196 strain is very well characterized genetically, this has been the first report on its production of ST. The allelic segregation rates and all the recombination frequencies between linked and non-linked genetic markers were determined by both the meiotic crossing UT448 (stc) x UT196 (stc+) and mitotic crossing UT448//UT184. 175 meiotic segregants and 140 mitotic segregants were analyzed as to ST production, auxotrophy markers and resistance to acriflavine. These crossed strains presented various markers in heterozygous configuration, which allowed to map a structural gene of ST (stcZ+) located on the left arm of chromosome I, 4% distant from the riboflavin gene (riboA1). As a byproduct of this work, a red pigment of 0.90 Rf was detected in all meiotic and mitotic segregants, whether they were ST producers or not, which indicated that was probably a polyketide produced by the fungus ascopores. The low expression of ST production in 13 meiotic segregants and the high expression of such toxin in the UT448//UT196 and UT448//UT184 diploids (40 ppm) allowed to conclude that a regulating factor existed in the w-met region of chromosome II, which is responsible for the expression of the structural gene stcZ+. The analyses of those genes through the parasexual cycle suggested a typical epigenetic behavior which involved them. Based on the data obtained, hypotheses to explain the expression control of these genes as well as their inter-relationships were here presented.

Spinal cord injury results in complete failure of the central neurons to regenerate and is associated with cyst formation and enlargement of the trauma zone. In contrast to the spinal cord, axons in the injured peripheral nerve have the capacity to undergo some spontaneous regeneration. However, significant post-traumatic loss of nervous tissue causing long nerve gap is one of the main reasons for the poor restoration of function following microsurgical repair of injured nerves. The present thesis investigates the effects of biodegradable conduits prepared from fibrin glue and poly-beta-hydroxybutyrate (PHB) in combination with cultured Schwann cells, mesenchymal stem cells and extracellular matrix molecules on regeneration after spinal cord and peripheral nerve injury in adult rats. At 4-8 weeks after transplantation into the injured spinal cord, the PHB conduit was well integrated into the cavity but regenerating axons were found mainly outside the PHB. When suspension of BrdU-labeled Schwann cells was added to the PHB, regenerating axons filled the conduit and became associated with the implanted cells. Modification of the PHB surface with extracellular matrix molecules significantly increased Schwann cell attachment and proliferation but did not alter axonal regeneration. To improve the labeling technique of the transplanted cells, the efficacy of fluorescent cell tracers Fast Blue, PKH26, Vibrant DiO and Cell Tracker™ Green CMFDA was evaluated. All tested dyes produced very efficient initial labeling of olfactory ensheathing glial cells in culture. The number of Fast Blue-labeled cells remained largely unchanged during the first 4 weeks whereas the number of cells labeled with other tracers was significantly reduced after 2 weeks. After transplantation into the spinal cord, Fast Blue-labeled glial cells survived for 8 weeks but demonstrated very limited migration from the injection sites. Additional immunostaining with glial and neuronal markers demonstrated transfer of the dye from the transplanted cells to the host tissue. In a sciatic nerve injury model, the extent of axonal regeneration through a 10mm gap bridged with tubular PHB conduit was compared with a fibrin glue conduit. At 2 weeks after injury, the fibrin conduit supported similar axonal regeneration and migration of the host Schwann cells compared with the PHB conduit augmented with a diluted fibrin matrix and GFP-labeled Schwann cells or mesenchymal stem cells. The long-term regenerative response was evaluated using retrograde neuronal labeling. The fibrin glue conduit promoted regeneration of 60% of sensory neurons and 52% of motoneurons when compared with the autologous nerve graft. The total number of myelinated axons in the distal nerve stump in the fibrin conduit group reached 86% of the nerve graft control and the weight of gastrocnemius and soleus muscles recovered to 82% and 89%, respectively. When a fibrin conduit was used to bridge a 20mm sciatic nerve gap, the weight of gastrocnemius muscle reached only 43% of the nerve graft control. The morphology of the muscle showed more chaotic appearance and the mean area and diameter of fast type fibers were significantly worse than those of the corresponding 10mm gap group. In contrast, both gap sizes treated with nerve graft showed similar fiber size. In summary, these results show that a PHB conduit promotes attachment, proliferation and survival of adult Schwann cells and supports marked axonal growth after transplantation into the injured spinal cord. The data suggest an advantage of the fibrin conduit for the important initial phase of peripheral nerve regeneration and demonstrate potential of the conduit to promote long-term neuronal regeneration and muscle recovery.

Among the myriad of naturally occurring bioactive compounds are the aminocyclopentitol-containing natural products that represent a family of sugar-derived microbial secondary metabolites, such as the antibiotics pactamycin, allosamidin, and trehazolin. Pactamycin, a structurally unique aminocyclitol antibiotic isolated from Streptomyces pactum, consists of a 5-membered ring aminocyclitol (cyclopentitol) unit, two aromatic rings (6-methylsalicylic acid (6-MSA) and 1-(3-Amino-phenyl)-ethanone or 3-aminoacetophenone) and a 1,1-dimethylurea. It has pronounced antibacterial, antitumor, antiviral, and antiplasmodial activities, but its development as a clinical drug was hampered by its broad cytotoxicity. Efforts to modulate its pharmacological and toxicity properties by structural modifications using synthetic organic chemistry have been difficult due to the complexity of its chemical structure. As part of our ongoing studies on the biosynthesis of aminocyclitol-derived bioactive natural products, we have identified the biosynthetic gene cluster of pactamycin in S. pactum ATCC 27456, which paves the way for a better understanding of pactamycin biosynthesis and generating novel pactamycin analogs through biosynthetic engineering. Through gene inactivations, feeding experiments, and in vitro enzymatic assay, we studied the biosynthesis of pactamycin, which include the modes of formation of the unique cyclopentitol unit, the 3-aminoacetophenone and the 6-methyl salicylic acid moieties. Armed with the tools needed to genetically engineer target strains of S. pactum, we were able to produce novel analogs of this untapped-class of natural products. TM-026 was generated from a ΔptmH (a radical SAM C-methyltransferase gene) mutant, whereas TM-025 was generated from a ΔptmH/ΔptmQ (a polyketide synthase gene) double knockout mutant. Both compounds show potent antimalarial activity, but lack significant antibacterial activity, and are about 10-30 times less toxic than pactamycin toward mammalian cells. The results suggest that distinct ribosomal binding selectivity or new mechanism(s) of action may be involved in their plasmodial growth inhibition, which may lead to the discovery of new antimalarial drugs and identification of new molecular targets within malarial parasites. TM-035 was also isolated from a ΔptmH mutant. However, we found that TM-035 showed no activity against bacteria, malarial parasites, and most tested mammalian cells, but it has potent growth inhibitory activity against two well-established human head and neck squamous cell carcinomas (SCC025 and SCC104) (IC₅₀ 725 nM) in an in vitro assay. More intriguingly, the compound is significantly less active against human primary epidermal keratinocytes (HPEK), demonstrating an interesting biological phenomenon and outstanding cell type selectivity, which may lead to the development of new anticancer chemotherapy. The production yield of pactamycin and its congeners under laboratory conditions is relatively low. This has hampered both mechanistic and preclinical studies of these promising compounds. To deepen our understanding of pactamycin biosynthesis and engineer mutant strains with improved production yields, we investigated pathway specific regulatory genes, ptmF and ptmE. Based on gene inactivation and RT-PCR studies, we found that the PtmF-PtmE system controls the transcription of the whole biosynthetic gene cluster. The results provide important insight into regulation of pactamycin biosynthesis and will contribute to future studies that aim at engineering high producing strains of S. pactum. / Graduation date: 2012 / Access restricted to the OSU Community at author's request from Feb. 28, 2012 - Feb. 28, 2013

A esterigmatocistina (ST) é uma micotoxina policetônica produzida por diferentes espécies de Aspergillus e outros gêneros fúngicos como Bipolaris e Chaetomium. Esta toxina é caracterizada como uma bifuranoxantona com fórmula molecular C18H12O6, freqüentemente encontrada como contaminante de diversos produtos alimentícios como sementes oleaginosas e cereais. Possui propriedades carcinogênicas, toxigênicas, mutagênicas e teratogênicas, entretanto, ela é menos tóxica do que a aflatoxina. O fungo Emericella nidulans (Eidam) Vuillemin, cujo anamorfo é o Aspergillus nidulans (Eidam) Winter, foi usado como modelo genético para a investigação de genes envolvidos na via biossintética da esterigmatocistina. Linhagens estoque de Utrecht (originárias de Glasgow) foram analisadas quanto à produção de ST e, entre elas, somente a linhagem UT196 [yA2 (I); metA17 (II); piroA4 (IV)] apresentou produção de 4 ppm de ST (stc+), enquanto que as linhagens UT448 e UT184 mostraram-se não produtoras dessa micotoxina (stc). Embora a linhagem UT196 seja muito bem caracterizada geneticamente, este foi o primeiro relato da produção de ST nessa linhagem. Os índices de segregação alélica e todas as freqüências de recombinação entre os marcadores genéticos ligados e não ligados foram determinados tanto pelo cruzamento meiótico UT448 (stc) x UT196 (stc+) como pelo cruzamento mitótico UT448//UT184. 175 segregantes meióticos e 140 segregantes mitóticos foram analisados quanto à produção de ST, aos marcadores de auxotrofia e de resistência a acriflavina. Essas linhagens cruzadas apresentavam vários marcadores em heterozigose e isso permitiu o mapeamento de um gene estrutural da ST (stcZ+), localizado no braço esquerdo do cromossomo I, 4% distante do gene da riboflavina (riboA1). Como um subproduto deste trabalho, foi detectado um pigmento vermelho, de Rf = 0,90, em todos os segregantes meióticos e mitóticos, produtores ou não de ST, indicando tratar-se, provavelmente, de um pigmento policetônico produzido pelos ascosporos do fungo. A baixa expressão da produção de ST em 13 segregantes meióticos e a alta expressão dessa toxina nos diplóides UT448//UT196 e UT448//UT184 (40 ppm) permitiram concluir a existência de um fator regulador, compreendido na região w-met do cromossomo II, responsável pela expressão do gene estrutural stcZ+. A análise desses genes através do ciclo parassexual sugeriu um comportamento epigenético típico envolvendo esses genes. Com base nos dados obtidos, hipóteses para explicar o controle da expressão desses genes e suas inter-relações foram aqui apresentadas. / Sterigmatocystin (ST) is a polyketide produced by different species of Aspergillus as well as by other fungus genera such as Bipolaris and Chaetomium. This toxin is characterized as a bifuranoxanthone, whose molecular formula is C18H12O6 and which is frequently found as a contaminant in several food products such as oil-seed grains and cereals. It has carcinogenic, toxigenic, mutagenic and teratogenic properties; however, it is less toxic than aflatoxin. The fungus Emericella nidulans (Eidam) Vuillemin, whose anamorph is Aspergillus nidulans (Eidam) Winter, was used as a genetic model to investigate the genes involved in the sterigmatocystin biosynthetic pathway. Strains from Utrecht stocks (originally from Glasgow) were analyzed in order to detect ST production and, among them, only the UT196 strain [yA2 (I); metA17 (II); piroA4 (IV)] showed the production of 4 ppm of ST (stc+), whereas the UT448 and UT184 strains showed to be nonproducers of such toxin (stc). Although the UT196 strain is very well characterized genetically, this has been the first report on its production of ST. The allelic segregation rates and all the recombination frequencies between linked and non-linked genetic markers were determined by both the meiotic crossing UT448 (stc) x UT196 (stc+) and mitotic crossing UT448//UT184. 175 meiotic segregants and 140 mitotic segregants were analyzed as to ST production, auxotrophy markers and resistance to acriflavine. These crossed strains presented various markers in heterozygous configuration, which allowed to map a structural gene of ST (stcZ+) located on the left arm of chromosome I, 4% distant from the riboflavin gene (riboA1). As a byproduct of this work, a red pigment of 0.90 Rf was detected in all meiotic and mitotic segregants, whether they were ST producers or not, which indicated that was probably a polyketide produced by the fungus ascopores. The low expression of ST production in 13 meiotic segregants and the high expression of such toxin in the UT448//UT196 and UT448//UT184 diploids (40 ppm) allowed to conclude that a regulating factor existed in the w-met region of chromosome II, which is responsible for the expression of the structural gene stcZ+. The analyses of those genes through the parasexual cycle suggested a typical epigenetic behavior which involved them. Based on the data obtained, hypotheses to explain the expression control of these genes as well as their inter-relationships were here presented.

Made available in DSpace on 2014-06-11T19:23:44Z (GMT). No. of bitstreams: 0 Previous issue date: 2007-02-14Bitstream added on 2014-06-13T20:11:30Z : No. of bitstreams: 1 iamaguti_ls_me_botfmvz.pdf: 753163 bytes, checksum: 213a9899967bd02b03e8f98c82bf083c (MD5) / Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) / O objetivo deste trabalho foi avaliar a aplicação de membrana biossintética de celulose (MBC) nacional, após a realização de trocleoplastia experimental em cães, com intuito de verificar se o uso desta poderia favorecer a migração de células com potencial condrogênico, assim como ocorre no tecido ósseo. A evolução pós-operatória dos cães foi analisada com especial interesse nos processos de reparação frente ao defeito osteocondral, estabelecendo as vantagens e desvantagens do uso do biomaterial. Foram utilizados 12 cães (Canis familiaris) adultos, sadios e sem alterações no aparelho locomotor. Todos os animais foram submetidos ao procedimento de trocleoplastia bilateral, sendo que a MBC foi aplicada no membro esquerdo. Os animais foram avaliados clínica e radiograficamente aos 15, 30, 60 e 90 dias de pós-operatório. A função locomotora do membro foi avaliada em escores pré-definidos, nos referidos momentos. A avaliação macroscópica da articulação foi realizada, nos momentos pré-estabelecidos, seguida da artrotomia exploratória, bem como da coleta de biópsia para o exame microscópico. Todos os animais apresentaram função normal dos membros nos momentos avaliados. Não houve diferença clínica e radiográfica entre os grupos controle (GC) e tratado (GT). Na avaliação histopatológica, aos 30 dias, notou-se intensa celularidade em ambos os grupos, sendo que no GC esta era constituída por fibroblastos ativos e no GT por condrócitos imaturos, formando um tecido conjuntivo mais organizado. O GC apresentava fibrose e muitos fibroblastos aos 60 dias, enquanto o GT apresentava maior número de condrócitos. Aos 90 dias, constatou-se formação de tecido do tipo fibrocartilaginoso maduro em ambos os grupos. Histomorfometricamente, o GT apresentou melhor resposta ao processo de reparação nos momentos iniciais quanto ao número de células e espessura do tecido... / The aim of this study was to evaluate the application of national biosynthetic cellulose membrane after experimental trochleoplasty, to verify if its utilization could support chondrogenic cells migration like occurs in osseous tissue. The advantages and disadvantages of the use of this biomaterial were evaluated through the observation of the reparative process of the osteochondral injury. Twelve adult healthy dogs (Canis familiaris) were used. All dogs were submitted to trochleoplasty in both pelvic limbs and the biosynthetic cellulose membrane was applied in the left limb. Clinical and radiographic evaluation was performed at 15, 30, 60 and 90 postoperatively. The locomotor function of the limb was evaluated in scores on the differents moments. The joint macroscopic evaluation was performed before exploratory arthrotomy and biopsy for microscopic exam. All dogs showed normal function of the limbs in all differents moments. Radiographic results showed no difference in control (CG) and treated groups (TG). Microscopic results showed at 30 days an increase of the celularity in both groups was observed. In the CG it was constituted by active fibroblasts and in TG by immatures condrocytes forming a more organized connective tissue. In the CG a fibrous tissue and many fibroblasts appear at 60 days and in the TG more condrocytes appear. A mature fibrocartilaginous tissue formed in both groups at 90 days. Histomorphometrically, TG presents better response of repair process in the fist moments as the number of cells and the tissue thickness. The biosynthetic cellulose membrane didn't cause deleterious effects showing good adaptation in intrarticular environment...(Complete abstract, access undermentioned eletronic address)

<div>Cyclic peptides are important sources of medicines. </div><div>They are advantageous compared to linear peptides because they possess lower flexibility, which allows for high-affinity target binding and enhanced proteolytic stability. Unfortunately, achieving head-to-tail cyclization of peptides is quite challenging, as it is hard to control efficiency and regiospecificity of peptide macrocyclization. Many have attempted to improve peptide cyclization, including the use of different synthetic reagents as well as synthetic techniques to allow amide-bond formation and promote cyclization. While these strategies have offered great potential solutions, the aim of this study is to explore an alternative strategy that utilizes biocatalysis as a method of achieving successful peptide cyclization. Biocatalysis is the use of enzymes as natural process catalysts under artificial in vitro conditions. Biocatalysis is often more environmentally friendly and safer compared to traditional organic synthesis methods. Non-ribosomal peptide synthetases (NRPSs) are one of the major sources of cyclic peptides in nature. These are systems of large multifunctional proteins are organized into functional domains that act as an assembly line to generate peptide natural products. Normally, the thioesterase domain is responsible for hydrolysis and cyclization of the peptide. Recently, a novel cyclase (SurE) that is physically discrete from the NRPS was discovered. Based on this unique quality, we hypothesized that SurE would be easier to express compared to thioesterase domains and, for this reason, SurE could be a fantastic biocatalyst for the cyclization of peptides. To test this, we designed and generated an expression vector for SurE. We then expressed and purified the SurE protein. We also synthesized three linear peptides of varying lengths. To test for SurE activity, we attempted to add N-acetylcysteamine (SNAC) to mimic its native substrate. Unfortunately, we were unable to successfully attach the SNAC to our linear peptide. To combat this issue, a new synthesis strategy is currently being developed. This work is currently ongoing in the Parkinson lab, with the aim being to test the SurE protein, as well as other PBP-like cyclases, on other modified linear peptides and demonstrate whether the protein has the ability to cyclase a wide scope of peptides.</div><div><br></div>

No description available.

No description available.

Thesis (MSc)--Stellenbosch University, 2012. / ENGLISH ABSTRACT: Physical and psychological stressors trigger activation of the hypothalamo-pituitary-adrenocortical (HPA) axis that leads to enhanced secretion of glucocorticoids e.g. cortisol. Moreover, chronic activation of this pathway may elevate oxidative stress that is linked to the onset of insulin resistance and cardiovascular diseases (CVD). Our laboratory previously found that oxidative stress increases flux through metabolic circuits such as the hexosamine biosynthetic pathway (HBP), in effect increasing its modification of target proteins post-transcriptionally with O-GlcNAc moeities. This in turn may alter protein function and contribute to the onset of myocardial insulin resistance and impaired contractile function. Since the underlying mechanisms linking chronic stress to cardiometabolic pathophysiology are poorly understood, we hypothesised that cortisol elicits myocardial oxidative stress, HBP activation, and decreased glucose uptake (due to attenuated glucose transport functionality) with detrimental outcomes, i.e. insulin resistance and apoptosis. To investigate this hypothesis we established an in vitro model using HL-1 cardiomyocytes, with which we evaluated the degree of O-GlcNAcylation and oxidative stress in response to a range of time-dose treatments with dexamethasone (synthetic glucocorticoid). Glucose transporter 4 (GLUT4) translocation to the sarcolemma was also assessed. In agreement with the literature, results suggest that GLUT4 translocation is significantly decreased subsequent to dexamethasone treatment. Although no significant differences were observed with regards to oxidative stress or O-GlcNAcylation, the data show that dexamethasone increased the latter with a maximal effect after two hours exposure to the 10-6 M dose. Although our results were not conclusive, the data suggest a potential novel link between dexamethasone exposure, HBP activation and decreased GLUT4 translocation. Based on our findings we propose that detrimental effects of chronic stress on the heart may be mediated by increased HBP flux. Given that glucocorticoid excess and GLUT4 dysregulation have been associated with insulin resistance (and related metabolic derangements and diseases), these results provide new targets for potential therapeutic agents. / AFRIKAANSE OPSOMMING: Fisiese sowel as psigologiese stressors veroorsaak die aktivering van die hipotalamiese-hipo seale-bynier (HHB) pad wat lei tot die verhoogde sekresie van glukokortikoïede soos kortisol. Kroniese aktivering van hierdie pad kan ook oksidatiewe stres verhoog wat weer tot insulienweerstandigheid en kardiovaskulêre siektes (KVS) kan lei. Navorsing uit ons laboratorium het voorheen bewys dat oksidatiewe stres 'n toename in vloei deur metaboliese paaie soos die heksoamine biosintetiese pad (HBP) kan veroorsaak deur die modi sering van teikenproteïene met O-GlcNAc motiewe. Dit kan weer proteïen funksie verander en bydra tot die ontstaan van miokardiale insulienweerstandigheid en verswakte kontraktiele funksie. Die onderliggende meganismes wat kroniese stres aan kardiometaboliese pato siologie verbind word nog nie goed verstaan nie, daarom is ons hipotese dat kortisol miokardiale oksidatiewe stres veroorsaak, die HBP pad aktiveer, en glukose opname verminder (deur die funksionele onderdrukking van glukose transport), wat nadelige uitkomste soos insulienweerstandigheid en apoptose tot gevolg kan hê. Om hierdie hipotese te ondersoek, is 'n in vitro model van HL-1 kardiomiosiete gebruik waarmee die graad van O-GlcNAsilering en oksidatiewe stres in reaksie op 'n reeks tyd-konsentrasie behandelings met deksametasoon (sintetiese glukokortikoïed), bepaal is. Glukose transporter 4 (GLUT4) translokasie na die sarkolemma is ook geasseseer. In ooreenstemming met die literatuur, is GLUT4 translokasie insiggewend onderdruk tydens deksometasoon behandeling. Alhoewel geen insiggewende verskille rakende oksidatiewe stres en O-GlcNAsilering gevind is nie, het ons data aangedui dat laasgenoemde deur deksametasoon vermeerder het na twee ure van blootstelling aan die 10-6 M konsentrasie. Alhoewel ons resultate geen afdoende bewys lewer nie, stel dit wel voor dat daar 'n potensiële verbintenis tussen deksametasoon behandeling en 'n afname in GLUT4 translokasie is. Gebasseer op ons bevindings, stel ons voor dat die nadelige e ekte van kroniese stres op die hart bemiddel kan word deur 'n toename in vloei deur die HBP. Gegewe dat 'n oormaat glukokortikoïede en GLUT4 wanregulering geassosieer is met insulien weerstandigheid (en verbandhoudende metaboliese veranderinge en siektes), verskaf hierdie resultate nuwe teikens vir potensiële terapeutiese ingrepe.

Thesis (MSc)--Stellenbosch University, 2008. / ENGLISH ABSTRACT: Gene expression of the cardiac isoform of acetyl-CoA carboxylase (ACCb) is induced in a glucose-dependent manner. ACCb produces malonyl-CoA, a potent inhibitor of mitochondrial fatty acid uptake. Previous studies show that increased flux through the hexosamine biosynthetic pathway (HBP) under hyperglycaemic conditions may contribute to the development of insulin resistance. In light of this, we hypothesised that increased HBP flux induces cardiac ACCb gene expression thereby contributing to the onset of insulin resistance. We tested our hypothesis by transiently transfecting cardiac-derived rat H9c2 myoblasts with a 1,317 bp human ACCb promoter-luciferase construct (pPIIb-1317) and an expression construct encoding the rate-limiting step of the HBP i.e. glutamine: fructose 6-phosphate amidotransferase (GFAT). Overexpression of GFAT increased ACCb gene promoter activity by 75 ± 23% versus controls (n=6, p<0.001). When cotransfection experiments were repeated in the presence of varying concentrations of L-glutamine (0 mM, 4 mM, 8 mM), a substrate for the HBP, ACCb promoter activity was dose-dependently increased. To further corroborate these findings, we employed two inhibitors of GFAT, i.e. 40 μM azaserine and 40 μM 6-diazo-5-oxo-Lnorleucine were administered to transfected cells for a period of 24 hours. Here both azaserine and 6-diazo-5-oxonorleucine attenuated ACCb gene promoter activity. In agreement, co-transfections with two dominant negative GFAT constructs also diminished ACCb gene promoter activity. We next inhibited two enzymes of the HBP acting downstream of GFAT, i.e. O-GlcNAc transferase and O-GlcNAcase using alloxan (0.1 mM, 1 mM and 2 mM) and streptozotocin (5 mM and 10 mM), respectively, for a period of 24 hours. Addition of alloxan attenuated ACCb gene promoter activity by 35.6 ± 1.9% (n=16, p<0.001) and streptozotocin increased activity by 32 ± 12% (n=12, p<0.001). We also investigated USF1 and USF2 as transcriptional regulatory candidates for HBP-induced ACCβ promoter regulation. Our data implicates USF2 as an important transcriptional regulator of HBP-induced ACCβ promoter regulation. In summary, this study demonstrates that increased flux through the hexosamine biosynthetic pathway induces ACCb gene promoter activity. We further propose that such an induction would reduce cardiac fatty acid oxidation, thereby leading to intracellular lipid accumulation due to a mismatch between sarcolemmal FA uptake and mitochondrial FA oxidation in the insulin resistant setting (i.e. hyperlipidaemia). / AFRIKAANSE OPSOMMING: Geen uitdrukking van die kardiale isoform asetiel-KoA karboksilase (ACCb) word in ‘n glukose afhanklike wyse geïnduseer. ACCb produseer maloniel-KoA, ‘n kragtige inhibeerder van mitochondriale vetsuuropname. Vorige studies toon aan dat verhoogde fluks deur die heksosamien biosintestiese weg (HBW) onder hiperglukemiese toestande bydra tot die ontwikkeling van insulienweerstand. In die lig hiervan, word daar gehipotetiseer dat verhoogde HBP fluks kardiale ACCb geenuitdrukking induseer en so bydra tot die ontstaan van insulienweerstand. Ons hipotese is getoets deur die kardiale afkomstige rot H9c2 mioblaste met ‘n 1.317 bp mens ACCb-lusiferase promotor konstruk (pPII-1317) te transfekteer en ‘n uitdrukking te konstrueer wat die tempo bepalende stap van HBP i.e. glutamien: fruktose-6-fosfaat amidotransferase (GFAT) kodeer. Ooruitdrukking van GFAT verhoog ACCb geenpromotor aktiviteit deur 75 ± 23% teenoor kontrole (n=6, p<0.001). Die herhaling van ko-transfeksie eksperimente is herhaal in die teenwoordigheid van variëerbare L-glutamienkonsentrasies (0 mM, 4 mM, 8 mM), ’n substraat vir die HBP, ACCb promotor aktiwiteit is dosisafhanglik verhoog. Om die bevindinge verder te staaf, is twee inhibeerders van GFAT, i.e. 40 μM azaserien en 40 μM 6-diazo-5-oxo-L-norleusien aan transfeksie selle toegedien vir ’n tydperk van 24 uur. Beide azaserien en 6-diazo-5-oxo-L-norleusien verlaag ACCb geenpromotor aktiwiteit. In ooreenstemming met die bogenoemde het ko-transfeksies met twee dominante negatiewe GFAT konstrukte ook ACCb geenpromoter aktiwiteit verminder. Die volgende stap is om twee ensieme van die HBP wat stroomaf van GFAT aktief is, vir ‘n periode van 24 uur te inhibeer i.e. O-GlcNAc transferase en O-GlcNAcase deur alloxan (0.1 mM, 1 mM en 2 mM) and streptozotosien (5 mM en 10 mM) onderskeidelik vir ‘n 24 uur periode te gebruik. Toevoeging van alloxan het die ACCb geenpromotor aktiwiteit by 35.6 ± 1.9% (n=16, p<0.001) verlaag en streptozotosien aktiwiteit verhoog by 32 ± 12% (n=12, p<0.001). Ons het ook die USF1 en USF2 as transkripsie regulerings kandidate vir HBP-geïnduseerde ACCβ promotor regulering ondersoek. Ons data impliseer dat USF2 as ‘n belangrike transkripsie reguleerder van HBP-geïndiseerde ACCβ promotor regulering is. Samevattend het hierdie studie demonstreer dat verhoogde fluks deur die hexosamien biosintetiese weg ACCb geenpromotor aktiwiteit induseer. Ons stel verder voor dat hierdie induksie die kardiale vetsuuroksidasie verlaag wat daartoe lei dat intrasellulêre lipied akkumulasie as gevolg van onparing tussen sarkolemma vetsuuropname en mitochondriale vetsuuroksidasie in ’n insulien weerstandige situasie (i.e. hiperlipidaemia).